Half-year statement of the liquidity contract between SCOR

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
23
Half-year statement of the liquidity contract between SCOR SE and EXANE BNP Paribas

Press Release

January 18, 2019 - N° 1

Half-year statement of the liquidity contract between SCOR SE and EXANE BNP Paribas

       

As per the liquidity contract granted by SCOR SE to EXANE BNP PARIBAS, as on December 31, 2018, the following assets appeared on the liquidity account:

- 120,728 SCOR SE shares, and

- EUR 13,790,289.

As a reminder, as of the last half-year statement (June 30, 2018), the following assets appeared on the liquidity account:

- 110,293 SCOR SE shares, and

- EUR 14,163,099.

*

*         *

Contact details

Marie-Laurence Bouchon

Group Head of Communications

+33 (0)1 58 44 75 43

mbouchon@scor.com

Ian Kelly

Head of Investor Relations

+44 (0)203 207 8561

ikelly@scor.com

http://www.scor.com/

Twitter: @SCOR_SE

Forward-looking statements

SCOR does not communicate "profit forecasts" in the sense of Article 2 of (EC) Regulation n°809/2004 of the European Commission. Thus, any forward-looking statements contained in this communication should not be held as corresponding to such profit forecasts. Information in this communication may include "forward-looking statements", including but not limited to statements that are predictions of or indicate future events, trends, plans or objectives, based on certain assumptions and include any statement which does not directly relate to a historical fact or current fact. Forward-looking statements are typically identified by words or phrases such as, without limitation, "anticipate", "assume", "believe", "continue", "estimate", "expect", "foresee", "intend", "may increase" and "may fluctuate" and similar expressions or by future or conditional verbs such as, without limitations, "will", "should", "would" and "could." Undue reliance should not be placed on such statements, because, by their nature, they are subject to known and unknown risks, uncertainties and other factors, which may cause actual results, on the one hand, to differ from any results expressed or implied by the present communication, on the other hand.

Please refer to the 2017 reference document filed on February 23, 2018, under number D.18-0072 with the French Autorité des marchés financiers (AMF) posted on SCOR's website www.scor.com (the "Document de Référence"), for a description of certain important factors, risks and uncertainties that may affect the business of the SCOR Group. As a result of the extreme and unprecedented volatility and disruption of the current global financial crisis, SCOR is exposed to significant financial, capital market and other risks, including movements in interest rates, credit spreads, equity prices, and currency movements, changes in rating agency policies or practices, and the lowering or loss of financial strength or other ratings.

The Group's financial information is prepared on the basis of IFRS and interpretations issued and approved by the European Union. This financial information does not constitute a set of financial statements for an interim period as defined by IAS 34 "Interim Financial Reporting".

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 6

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 1

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 1

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 3

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 2

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 1

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 3

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Investor Conferences to Watch This Quarter for Growth

Updated Category News Views 256

Introduction to Q1 Investor Conferences This year has begun with a dynamic mix of geopolitical events that have positively impacted domestic energy-sector stocks. As we venture into 2026, the buzz around technological advancements, especially in artificial intelligence, is palpable. Investors are keenly awaiting insights and trends that will be presented at various...

Continue Reading
Triton Digital Unveils U.S. Podcast Rankings for November 2024

Updated Category News Views 191

Overview of the November 2024 Podcast Metrics Triton Digital, a leading provider of technology and services in the digital audio and podcasting sector, has unveiled its reporting period for November 2024, covering from November 4 to December 1. This release comes from Triton’s Podcast Metrics measurement service, which offers critical insights into podcast performances...

Continue Reading
Treasury Bonds Auction Insights: RIKB 26 1015 & RIKB 38 0215

Updated Category News Views 150

Overview of Treasury Bonds Auction Results In a recent auction, two significant treasury bonds were featured: RIKB 26 1015 and RIKB 38 0215. The auction process is a crucial activity in the finance world, presenting opportunities for investors to acquire bonds issued by the government. Each bond serves different funding needs, making it essential to assess their...

Continue Reading
DeepQure's New Clinical Leadership: A Vision for Hypertension Care

Updated Category News Views 162

DeepQure Welcomes New Global Vice President DeepQure, a trailblazer in innovative treatments for hypertension, has made a significant step forward with the recent appointment of Jason G. Jones as the Global Vice President of Clinical & Regulatory Affairs. This strategic move is expected to amplify DeepQure's ambitions as it seeks to redefine hypertension management with...

Continue Reading
Wave Life Sciences Unveils Promising Data for WVE-007 Obesity Therapy

Updated Category News Views 236

Wave Life Sciences Presents Preclinical Findings at ObesityWeek 2025 Wave Life Sciences Ltd. (NASDAQ: WVE), a pioneering biotechnology firm, is excited to share breakthrough preclinical data on WVE-007, an innovative siRNA therapeutic targeting obesity. This research will be spotlighted in a poster presentation at ObesityWeek 2025, which features insights into how WVE-007...

Continue Reading